Termination Decision: Post-DI Settlement | Jan 25, 2023 | PAPER | BOARD |
Joint Motion to Terminate Proceeding | Jan 3, 2023 | PAPER | PATENT OWNER |
Joint Request to File Settlement Agreement as Business Confidential Information | Jan 3, 2023 | PAPER | PATENT OWNER |
Patent Owner's Updated Exhibit List | Jan 3, 2023 | PAPER | PATENT OWNER |
CONFIDENTIAL Term Sheet | Jan 3, 2023 | EXHIBIT | PATENT OWNER |
Patent Owner's Response | Nov 4, 2022 | PAPER | PATENT OWNER |
Patent Owner's Updated Exhibit List as of November 4, 2022 | Nov 4, 2022 | PAPER | PATENT OWNER |
Declaration of Dr. Sushrut S. Waikar | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Waikar CV | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Declaration of Dr. Neil Solomons | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Declaration of Dr. Robert Huizinga | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Declaration of Laura Veasey | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Declaration of Rosnawati Yahya | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Declaration of Abdul Halim Abdul Gafor | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Mittal 2016 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
European FK Psoriasis Study Group 1996 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
NCT02630628 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Liu 2015 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
NCT01328834 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
NCT01316133 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
NCT00615173 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Lupkynis Label 2021 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Benlysta Label 2022 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Nieto 2016 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
NCT00295425 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
NCT01224041 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
NCT01511003 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
NCT05221411 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Gupta Poster Presentation | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
UKKA Guideline_Part 1 of 4 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
UKKA Guideline_Part 2 of 4 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
UKKA Guideline_Part 3 of 4 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
UKKA Guideline_Part 4 of 4 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Hannah 2016 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Ayoub 2017 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Holtkamp 2011 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
NCT01342016 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Furie 2014 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Mysler 2013 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Rovin 2012 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
NCT02260934 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
NCT01499355 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
NCT02547922 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
NCT02176486 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
NCT02550652 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Dekkers 2018 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Furie 2015 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Houssiau 2014 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Gaston Poster Presentation | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
FDA Rituxan 2006 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
FDA Ocrelizumab 2017 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Busque 2007 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
PDR Orencia 2015 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Rahman 2012 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Papp 2006 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Corapi 2015 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Qin 2017 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Stalder 2003 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Nat'l Kidney Foundation, Kidney Tests | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
American Kidney Fund, Serum creatinine test | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Jaimes Biography | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Akhyani 2010 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Bissonnette 2006 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Calizo 2019 Supplemental Info | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Calizo 2019 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
www.europeanpharmaceuticalreview.com | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
www.drugs.com | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Anglade 2008 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Dumont 2004 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Yatscoff 2003 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
www.healio.com | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Kirsten 2016 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Jaimes Deposition Transcript | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Rovin 2021 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Rovin 2021 Supplement | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Waikar 2009 | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
www.rheumatologynetwork.com | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Cruitt Declaration | Nov 4, 2022 | EXHIBIT | PATENT OWNER |
Rehearing: Denying Decision on Request for Rehearing | Oct 20, 2022 | PAPER | BOARD |
Patent Owner's Second Amended Notice of Deposition of Dr. Edgar A. Jaimes | Oct 13, 2022 | PAPER | PATENT OWNER |
Order: Denying POP Request | Oct 5, 2022 | PAPER | BOARD |
Patent Owner's Amended Notice of Deposition of Dr. Edgar A. Jaimes | Sep 14, 2022 | PAPER | PATENT OWNER |
Notice of Stipulation to Extend Due Dates 1 - 3 | Sep 13, 2022 | PAPER | PATENT OWNER |
Patent Owner's Notice of Deposition of Dr. Edgar A. Jaimes | Sep 7, 2022 | PAPER | PATENT OWNER |
Petitioner's Unopposed Motion for Pro Hac Vice Admission of Dr. Casey M. Kraning | Aug 29, 2022 | PAPER | PETITIONER |
Declaration of Dr. Casey M. Kraning | Aug 29, 2022 | EXHIBIT | PETITIONER |
Ex. 3001 POP Request | Aug 10, 2022 | EXHIBIT | BOARD |
Notice: notice of receipt of POP request | Aug 10, 2022 | PAPER | BOARD |
Patent Owner's Objections to Petitioner's Evidence | Aug 9, 2022 | PAPER | PATENT OWNER |
Patent Owner's Request for Rehearing of the Institution Decision | Aug 9, 2022 | PAPER | PATENT OWNER |
Institution Decision | Jul 26, 2022 | PAPER | BOARD |
Scheduling Order | Jul 26, 2022 | PAPER | BOARD |
Patent Owner's Preliminary Response | Jun 16, 2022 | PAPER | PATENT OWNER |
Patent Owner's Exhibit List | Jun 16, 2022 | PAPER | PATENT OWNER |
Ryan and Menter 2015 | Jun 16, 2022 | EXHIBIT | PATENT OWNER |
Uveitis treatment fails phase 3 trial - American Academy of Ophthalmology | Jun 16, 2022 | EXHIBIT | PATENT OWNER |
Patent Owner's Updated Mandatory Notices | Apr 25, 2022 | PAPER | PATENT OWNER |
Notice: Notice filing date accorded | Mar 17, 2022 | PAPER | BOARD |
Patent Owner's Mandatory Notices | Mar 17, 2022 | PAPER | PATENT OWNER |
Patent Owner's Power of Attorney and Designation of Lead and Backup Counsel | Mar 17, 2022 | PAPER | PATENT OWNER |
U.S. Patent No. 10,286,036 | Feb 24, 2022 | EXHIBIT | PETITIONER |
Excerpts from the Prosecution History of U.S. Patent No. 10,286,036 Part 1 of 2 | Feb 24, 2022 | EXHIBIT | PETITIONER |
Excerpts from the Prosecution History of U.S. Patent No. 10,286,036 Part 2 or 2 | Feb 24, 2022 | EXHIBIT | PETITIONER |
Curriculum Vitae of Dr. Edgar A. Jaimes | Feb 24, 2022 | EXHIBIT | PETITIONER |
AURA-LV: Aurinia Urinary Protein Reduction Active ��� Lupus with Voclosporin (AURA) (AURA-LV), Clinical Study NCT02141672 | Feb 24, 2022 | EXHIBIT | PETITIONER |
Papp K. et al., "Efficacy of ISA247 in plaque psoriasis: a randomized, multicenter, double-blind, placebo-controlled phase III study," Lancet (2008) | Feb 24, 2022 | EXHIBIT | PETITIONER |
Ha et al., "Increased risk of everolimus-associated acute kidney injury in cancer patients with impaired kidney function," BMC Cancer (2014) | Feb 24, 2022 | EXHIBIT | PETITIONER |
History of Changes for Study NCT02141672 (AURA-LV), comparison of May 15, 2014 | Feb 24, 2022 | EXHIBIT | PETITIONER |
Parikh S.V. and Rovin B.H., "Current and emerging therapies for lupus nephritis," J. Am. Soc. Nephrol. (2016) | Feb 24, 2022 | EXHIBIT | PETITIONER |
U.S. Patent No. 7,332,472 | Feb 24, 2022 | EXHIBIT | PETITIONER |
Ling S.Y. et al., "Pharmacokinetics of voclosporin in renal impairment and hepatic impairment," J. Clin. Pharmacol. (2013) | Feb 24, 2022 | EXHIBIT | PETITIONER |
Gheith et al., "Next-generation calcineurin inhibitors in development for the prevention of organ rejection," Transpl. Res. Risk Manag. (2014) | Feb 24, 2022 | EXHIBIT | PETITIONER |
Rovin B.H. et al., Kidney Int'l (2019) | Feb 24, 2022 | EXHIBIT | PETITIONER |
Lupus Foundation of America: National Resource Center on Lupus | Feb 24, 2022 | EXHIBIT | PETITIONER |
Levey A.S. et al., Ann. Intern. Med. (1999) | Feb 24, 2022 | EXHIBIT | PETITIONER |
Boele-Schutte et al., Nephrol. Dial. Transplant. (2017) | Feb 24, 2022 | EXHIBIT | PETITIONER |
Chang D. R. et al., Sci. Rep. (2021) | Feb 24, 2022 | EXHIBIT | PETITIONER |
A brief history on the estimation of Glomerular Filtration Rate (2022) | Feb 24, 2022 | EXHIBIT | PETITIONER |
National Kidney Foundation. KDOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification (2002) | Feb 24, 2022 | EXHIBIT | PETITIONER |
Huizinga R.B. et al., LUPUS (2017) | Feb 24, 2022 | EXHIBIT | PETITIONER |
Keane W.F., Eknoyan G., Am. J. Kidney Dis. (1999) | Feb 24, 2022 | EXHIBIT | PETITIONER |
Almaani et al., Clin. J. Am. Soc. Nephrol. (2017) | Feb 24, 2022 | EXHIBIT | PETITIONER |
Li X. et al., Nephrol. Dial. Transplant. (2012) | Feb 24, 2022 | EXHIBIT | PETITIONER |
Alamilla-Sanchez M.E. et al., Int. J. Nephrol. Renov. Dis. (2021) | Feb 24, 2022 | EXHIBIT | PETITIONER |
Huizinga R.B. et al., The 12th International Congress on Systemic Lupus Erythematosus (LUPUS 2017) | Feb 24, 2022 | EXHIBIT | PETITIONER |
Aurinia Press Release, March 1, 2017 | Feb 24, 2022 | EXHIBIT | PETITIONER |
Label for Afinitor (everolimus) tablets for oral administration, Novartis, revised 07/2012 | Feb 24, 2022 | EXHIBIT | PETITIONER |
Busque S. et al., Am. J. Transplant. (2011) | Feb 24, 2022 | EXHIBIT | PETITIONER |
Food and Drug Administration Amendments Act of 2007 | Feb 24, 2022 | EXHIBIT | PETITIONER |
Aurinia Press Release, February 5, 2017 | Feb 24, 2022 | EXHIBIT | PETITIONER |
USPTO Assignment Record for U.S. Pat. No. 10,286,036 | Feb 24, 2022 | EXHIBIT | PETITIONER |
Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations | Feb 24, 2022 | EXHIBIT | PETITIONER |
Internet Archive Declaration from Nathaniel E. Frank-White, February 10, 2022 | Feb 24, 2022 | EXHIBIT | PETITIONER |
Comprehensive Clinical Nephrology, R.J. Johnson, J. Feehally, and J. Floege (Eds.), Elsevier Saunders (2015) | Feb 24, 2022 | EXHIBIT | PETITIONER |
Declaration of Dr. Edgar A. Jaimes | Feb 24, 2022 | EXHIBIT | PETITIONER |
Petitioner's Power of Attorney | Feb 24, 2022 | PAPER | PETITIONER |
Petition for Inter Partes Review of the '036 Patent | Feb 24, 2022 | PAPER | PETITIONER |